𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Processing and presentation of tumor antigens and vaccination strategies

✍ Scribed by Pierre van der Bruggen; Benoît J Van den Eynde

Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
208 KB
Volume
18
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

✦ Synopsis

Various new aspects of antigen processing have been uncovered through the study of tumor antigens. One of these is the production of antigenic peptides by splicing of two distinct peptide fragments. In one of the two cases reported, the proteasome was found to be responsible for splicing. The presentation of another peptide on major histocompatibility complex class I molecules was found to depend on secretion and reuptake of the parent protein, implying a cross-presentation pathway in melanoma cells. Class II presentation of peptides derived from cytosolic proteins now appears to result from autophagy. Based on increased knowledge on antigen processing and presentation, new vaccination strategies are aimed at improving the targeting of antigens to dendritic cells, promoting cross-priming (for example, using chloroquine), improving peptide binding to class I molecules and targeting antigens to both the class I and the class II pathways.

📜 SIMILAR VOLUMES

Antigen presentation, antigen-presenting
Antigen presentation, antigen-presenting cells and antigen processing
✍ D.R. Katz 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 812 KB

To summarize, during the period under review there have been considerable advances in our understanding of how antigen is associated with MHC on the surface of a presenting cell. Basic rules which govern this association have been confirmed as including both the nature and the configuration of the a

Tumor antigens and tumor vaccines: Pepti
Tumor antigens and tumor vaccines: Peptides as immunogens
✍ Craig L. Slingluff Jr 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 906 KB

Tumor antigens recognized by human cytotoxic T lymphocytes (CTL) have been identified for multiple types of solid tumors. These include both shared and unique antigens. Unique antigens are those expressed uniquely by one patient's tumor, and shared antigens are those present on tumor cells from many